Research at Baptist Health Corbin

Medical research represents the future of healthcare. That’s why Baptist Health hospitals participate in clinical research projects. This participation is a key part of our organization-wide commitment to improving medical outcomes for patients both today and tomorrow. Our research focus at Baptist Health Corbin is cancer research. Our oncology team offers patients innovative treatment options that contribute to an improved understanding of cancer and how best to fight the disease and win.

Current Research

Below is a list of clinical trials currently underway at Baptist Health Corbin:

• NRG BR003: A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node- Negative Triple Negative Breast Cancer 

• ALLIANCE A151216: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) 

• EAY131: Molecular Analysis for Therapy Choice (MATCH)

• BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab  with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

• GI004: Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/ Bevacizumab/ Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer

• ASCEND II:  Detecting cancers Earlier Through Elective plasma-based CancerSEEK Testing – Ascertaining Serial Cancer patients to Enable New Diagnostic II (DETECT-ASCEND 2)

• VastBiome:  PARADIGM: Pursuit to Analyze and Reveal Associated Drivers of Immunotherapy outcomes through the Gut Microbiome.

A Team Approach to Research

Research is a team effort. The oncology team at Baptist Health Corbin is always on the lookout for groundbreaking clinical trials that offer new hope to patients living with cancer. We have several ongoing studies that target different types and stages of cancer, but with an emphasis on those most prevalent in our region. Our research staff identifies and screens patients on a daily basis to provide them with treatment options that go beyond standard levels of care.

Putting Cancer on Trial

The Baptist Health Corbin oncology team offers a number of services that are vital to the success of clinical research:

• Participation in federally sponsored trials that provide new treatment opportunities for various medical conditions and diseases.
• Trial-matching patients to studies taking place both inside and outside Baptist Health.
• Collaboration with other hospitals and treatment centers to find the best possible fit between patients and research initiatives.

Areas of Emphasis

The Baptist Health Corbin research program focuses on studying and treating cancer. We are currently conducting treatment and maintenance trials involving lung, breast, brain, and pancreatic cancers. By participating in clinical trials, patients have the opportunity to receive novel treatments, in addition to making positive contributions to the future of medicine.

Program Highlights

The research program’s success has led to the expansion of the oncology team at Baptist Health Corbin. The hospital is fully committed to further growth in the years to come.